113 results
8-K
EX-99.1
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
products continue to deliver impressive results with high patient satisfaction, with no adverse events. We are investing in sales improvement and long … -term opportunities with all of our products.
Q4 Financial Results
We recorded revenues of approximately $1.2 million for the quarter ended December 31
8-K
EX-10.8
NAOV
NanoVibronix Inc
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
, the Company currently sponsors and maintains the NanoVibronix, Inc. 2014 Long-Term Incentive Plan (the “Plan”);
WHEREAS, pursuant to the terms
8-K
EX-10.2
NAOV
NanoVibronix Inc
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
, the Company currently sponsors and maintains the NanoVibronix, Inc. 2014 Long-Term Incentive Plan (the “Plan”);
WHEREAS, pursuant to the terms
8-K
EX-10.3
ogexp9kaiu
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.5
0hlcav73ec5q2
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.7
0ddsiwa3zsyoip3lrwz
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.9
aamxaa
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.1
40z 4d8f4rzb
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.4
p1dw7skvcf3f zm3ga
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.6
zc5l71w8
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-99.1
h2yaax e6sm4
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
EX-99.1
8qx0u1lsm a9jgb3
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am